Scientists have developed a single-dose treatment for breast cancer that eliminates small tumors and significantly shrinks ...
Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment typically involves surgery and follow-up hormone therapy, but late effects ...
More testing is needed, but if the same results are seen in humans, it could transform treatment of the disease.
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.
Elinzanetant reduced vasomotor symptoms frequency and severity in women with or at high risk of HR-positive breast cancer in ...
A revolutionary new treatment for breast cancer has shown the ability to eliminate small breast tumors and significantly ...
Researchers are exploring how to prolong ovarian life and revisiting hormone replacement therapy — a once routine treatment ...
Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women.
The FDA has approved Datroway (datopotamab deruxtecan) to treat adults with unresectable or metastatic, HR+, HER2- breast cancer who have received prior endocrine therapy and chemotherapy.
NDAQ:COSM) Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million ...
The addition of anthracyclines to adjuvant taxane-based chemotherapy improved survival for certain high-risk patients with ...
A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) on December 5, 2024, Volume 16, Issue 22, titled "DNA-methylation age and ...